Shares of Moderna 4.5% to $162.69 at 11:10 EST on Friday, after two sessions in a row of . The Nasdaq Stock Market is 0.23% to $12,376.90, following yesterday’s upward trend, This seems, , a somewhat trend today.
Moderna’s last close was $155.69, 9.72% its 52-week high of $178.50.
Moderna’s sales growth is 1428.1% for the quarter and 13065.3% for the next. The company’s growth estimates for the quarter is a negative 48.6% and positive 565.7% for the next.
Year-on-year quarterly revenue growth by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s Stock Top and Bottom Yearly Value
Moderna’s stock is at $162.69 at 11:10 EST, its 52-week high of $178.50 and way its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s is way its 50-day moving average of $101.27 and way its 200-day moving average of $76.37.
Previous days news about Moderna
Moderna says Swiss government has increased its Covid vaccine order to 7.5 million doses from 4.5 million. According to MarketWatch on Tue Dec 8, “Moderna Inc. said Tuesday the Swiss government has increased its order for Moderna’s COVID-19 vaccine candidate to 7.5 million doses from an original 4.5 million.”
Moderna offers U.S. fail-safe on vaccines if Pfizer falls short. According to Bloomberg Quint on Thu Dec 10, “Moderna Inc. could offer a fail-safe option that will allow the U.S. to get enough Covid-19 shots to inoculate most Americans if the government can’t reach an agreement to quickly buy more vaccine from Pfizer Inc., which plans to honor its contracts with other countries.”